Advertisement
Home 2018 February

Monthly Archives: February 2018

Use of antihypertensive treatments during delivery hospitalizations in women with preeclampsia has increased since 2006

Rise in Use of Antihypertensives in Delivery With Preeclampsia

0
Treatment trend associated with decreased risk of maternal stroke over same time period
Short stature at 7 to 13 years is significantly associated with increased risks in adulthood of ischemic stroke in both sexes and intracerebral hemorrhage in men

Short Stature in Childhood Tied to Higher Stroke Risk in Adulthood

0
Increased risk seen for ischemic stroke in both sexes, intracerebral hemorrhage in men
A new questionnaire can measure the impact of brachial plexus injury and assess surgical outcomes

New Tool Measures Impact of Brachial Plexus Injury

0
Questionnaire measures physical, psychological effects; valid based on comparison with other tools
After induction short-term intensive insulin therapy (IIT)

Metformin After Induction Tx May Preserve Beta-Cell Function

0
Also associated with better glycemic control than repeat intensive insulin therapy after induction IIT
Intravenous acetaminophen with or without ketorolac is associated with reduced opioid consumption and cost of care after scoliosis surgery in adolescents

Opioids Plus Acetaminophen, Ketorolac Cost-Effective Post-Sx

0
In children having scoliosis surgery, combo is linked to reduced opioid intake compared with opioids alone
Laryngovideostroboscopy is effective for screening each patient with persistent dysphonia for vocal fold lesions

Laryngovideostroboscopy Useful for Vocal Fold Lesion Screening

0
Narrow band imaging better for decision to biopsy
Erleada (apalutamide) has been approved by the U.S. Food and Drug Administration to treat non-metastatic

FDA Approves Erleada to Treat Non-Metastatic Prostate Cancer

0
First FDA-approved treatment for non-metastatic, castration-resistant prostate cancer
The first blood test designed to help health care professionals evaluate mild traumatic brain injury has been approved by the U.S. Food and Drug Administration.

FDA Approves First Blood Test to Evaluate Potential Concussions

0
Should help reduce unnecessary CT testing and associated radiation exposure
For hospitalized patients with heart failure with preserved ejection fraction

Poor Outcomes With Systolic BP Below 120 mm Hg in HFpEF

0
Increased risk of heart failure readmission at 30 days; of mortality, combined end point at 30 days, one year
Both focused attention and progressive muscle relaxation result in reductions in seizure frequency in patients with epilepsy

Stress Reduction May Help Reduce Epileptic Seizures

0
Both focused attention and progressive muscle relaxation techniques cut seizures